Get the Stockscreener App
1.79
1.13%
0.02
Seer Inc stock is traded at $1.79, with a volume of 559.40K.
It is up +1.13% in the last 24 hours and down -9.60% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.77
Open:
$1.79
24h Volume:
559.40K
Relative Volume:
1.44
Market Cap:
$98.42M
Revenue:
$15.04M
Net Income/Loss:
$-70.49M
P/E Ratio:
-1.4384
EPS:
-1.2444
Net Cash Flow:
$-49.88M
1W Performance:
+4.07%
1M Performance:
-9.60%
6M Performance:
-9.14%
1Y Performance:
-13.94%
1-Day Range:
$1.72
$1.7992
1-Week Range:
$1.67
$1.7992
52-Week Range:
$1.65
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.79 | 97.32M | 15.04M | -70.49M | -49.88M | -1.2444 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer reaffirms $16M-$18M 2026 revenue guidance amid new patent suit and commercial leadership hire - MSN
Seer (SEER) price target increased by 33.33% to 4.08 - MSN
Seer, Inc. Board Unanimously Rejects Radoff-JEC Group’s $2.40 Per Share Acquisition Proposal as Undervalued 1 - Minichart
Seer, Inc Issues a Press Release to Shareholders - marketscreener.com
Seer, Inc Provides Information to Shareholders - marketscreener.com
Seer Board Unanimously Rejects $2.40-per-share Unsolicited Acquisition Proposal - TradingView
Seer (NASDAQ: SEER) board rebuffs $2.40 cash offer from Radoff-JEC - Stock Titan
Seer (SEER) Board Rejects Acquisition Proposal, Citing Undervaluation - GuruFocus
Seer stock falls as board rejects revised takeover bid By Investing.com - Investing.com South Africa
Seer's Board Rejects Revised Unsolicited Proposal From Radoff-JEC Group - Moomoo
Seer stock falls as board rejects revised takeover bid - Investing.com
The Board of Directors of Seer, Inc. has unanimously rejected the further revised unsolicited acquisition proposal submitted by the Radoff-Jec Group. - bitget.com
Seer (NASDAQ: SEER) CFO sells 7,303 shares to cover RSU tax obligations - Stock Titan
Seer board rejects revised $2.40 per share acquisition proposal By Investing.com - Investing.com Canada
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group - The Manila Times
Seer Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group - marketscreener.com
[PREC14A] Seer, Inc. Preliminary Contested Proxy Statement - Stock Titan
Seer stock rises after investor group sweetens takeover bid - MSN
Seer (SEER) faces proxy contest as Radoff-JEC holds ~7.6% stake - Stock Titan
Seer Q1 earnings call highlights - MSN
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates - MSN
Seer files patent infringement lawsuit against Nanomics Biotechnology - MSN
Seer, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-05-16 - Seeking Alpha
Seer (NASDAQ: SEER) Amendment: Farokhzad 6.92M shares, 12.0% ownership - Stock Titan
Seer, Inc. (NASDAQ:SEER) Q1 2026 Earnings Call Transcript - Insider Monkey
Seer Earnings Call Balances Near-Term Pain, Long-Term Promise - TipRanks
Seer (SEER) Shareholders Face New Acquisition Proposal Amid Disa - GuruFocus
Seer (SEER) Stock Rises Over 7% Amid Acquisition Bid - GuruFocus
Seer (SEER) Shares Surge as Acquisition Offer Increases to $2.40 - GuruFocus
Seer joins Thermo Fisher tools in large-scale proteomics effort - MSN
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc - marketscreener.com
Radoff-JEC Group Raises Bid for Seer in Escalating Governance Fight - citybiz
Seer, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
The Radoff-JEC Group Submits Its Third Non-Binding Proposal To Acquire Seer, Inc. SEER - Moomoo
Canaccord reiterates Buy on Seer stock, cites long-term potential By Investing.com - Investing.com Nigeria
Canaccord reiterates Buy on Seer stock, cites long-term potential - Investing.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Horn David R. | PRESIDENT & CFO |
Feb 18 '26 |
Sale |
1.99 |
7,743 |
15,447 |
501,262 |
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):